Funding for this research was provided by:
European Union's Seventh Framework Programme FP7 (306088)
National Cancer Institute
Susan G. Komen for the Cure
Received: 20 May 2017
Accepted: 10 November 2017
First Online: 28 November 2017
Ethics approval and consent to participate
: Written informed consent was not required for this study as women automatically consent to the use of their anonymized data for scientific purposes by participating in screening unless they object. A waiver from the research ethics committee of the Radboud University Medical Center was obtained to use the anonymized images.
: Not applicable.
: IS has a research agreement and speaking agreement with Siemens AG, and a research agreement with Toshiba Medical Systems Corporation. RMM has a research agreement with Siemens AG, Seno Medical Instruments Inc., and Identification solutions Inc. GJdH is a founder and employee of Sigmascreening. CHvG reports non-financial support from Volpara Health Technologies outside the submitted work. NK is a shareholder and consultant to Volpara Health Technologies, a director and shareholder of ScreenPoint Medical, and a shareholder and consultant to Qview Medical. KH declares that she has no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.